Cargando…
Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country
OBJECTIVES: Breast cancer immunohistochemistry (IHC) biomarker testing is limited in low-resource settings, and an alternative solution is needed. A point-of-care mRNA STRAT4 breast cancer assay for ESR1, PGR, ERBB2, and MKi67, for use on the GeneXpert platform, has been recently validated on tissue...
Autores principales: | Mugabe, Marcellin, Ho, Kenneth E, Ruhangaza, Deo, Milner, Dan, Rugwizangoga, Belson, Chu, Victor C, Wu, Natalie C, Rizo, Annaliza, Weidler, Jodi M, Wong, Wendy, Bates, Michael, Brock, Jane E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512210/ https://www.ncbi.nlm.nih.gov/pubmed/34050358 http://dx.doi.org/10.1093/ajcp/aqab016 |
Ejemplares similares
-
Pathology Characteristics of Lymphomas in Rwanda: A Retrospective Study
por: Byiringiro, Fiacre Mugabe, et al.
Publicado: (2021) -
Pathological Characteristics, Prognostic Determinants and the Outcome of Patients Diagnosed with Colorectal Adenocarcinoma at the University Teaching Hospital of Kigali
por: Uwamariya, Delphine, et al.
Publicado: (2022) -
XPERT(®) breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results)
por: Borges, Pamela C C, et al.
Publicado: (2023) -
Blastic Plasmacytoid Dendritic Cell Neoplasm: First Case Report From Rwanda and Review of the Literature
por: Ruhangaza, Deogratias, et al.
Publicado: (2019) -
Response to Hulliard, Le Strat, Dubertre, et al.
por: Carreira, Helena, et al.
Publicado: (2019)